Market Access Manager, EU Center

The role

You will secure and sustain patient access to medicines across the DACH region. You will own the German AMNOG process end to end and lead reimbursement submissions in Austria and Switzerland.

What you will do

• Lead AMNOG value dossiers end to end
• Own G-BA and IQWiG interactions
• Prepare and support price negotiations
• Drive regional payer engagement
• Secure hospital and clinic reimbursement
• Resolve access barriers in the field
• Extend access beyond Germany to Austria and Switzerland

Required qualifications

• Degree in health economics, pharmacy, medicine, life sciences or a comparable field
• 5–8 years of experience in market access or HTA in the pharmaceutical industry, a consultancy or a specialised HTA service provider
• Demonstrated experience preparing AMNOG value dossiers under § 35a SGB V
• Hands-on involvement in a reimbursement price negotiation under § 130b SGB V
• Solid command of G-BA and IQWiG methodology, procedural rules and statutory timelines
• Experience engaging payers and/or hospitals directly on reimbursement matters
• Strong written argumentation
• Business-fluent German and English
• Willingness to travel approximately 20% of working time

Nice to have

• Experience as project lead on at least one complete AMNOG procedure
• Knowledge of German hospital financing (NUB, DRG, additional payments)
• Knowledge of reimbursement in Austria and Switzerland
• Experience with orphan drugs or a limited evidence base

Benefits

• Market-leading compensation
• Hybrid work model
• Career development through regular feedback, continuous education and professional development programs
• Financial rewards for strong performance
• Peer-to-peer recognition
• Growth opportunities

About the company

BridgeBio uses a moneyball for biotech approach to pool projects and early-stage research to reduce risk and unleash innovation. They develop medicines for patients with unmet needs in rare diseases.